Table 2. Distribution of the LGALS9 alleles and genotypes in patients with RA and healthy individuals.

SNP genotype	RA		Control		p-value	RR	OR (95%IC)
rs4795835	(N = 154)	%	(N = 195)	%
CC	103	66.88	109	55.89	0.063	0.83	0.65 (0.42–1.01)
CT	44	28.57	80	41.03	0.025	1.25	1.69 (1.08–2.64)
TT	7	4.54	6	3.07	0.415	0.76	0.59 (0.20–1.75)
CT and TT	51	33.11	86	44.10	0.063	1.20	1.52 (0.98–2.34)
C- allele	250	81.16	298	76.41	0.233	0.90	0.79 (0.54–1.13)
T-allele	58	18.83	92	23.58	0.233	1.10	1.26 (0.87–1.81)
rs3763959	(N = 105)	%	(N = 192)
AA	7	6.67	29	15.10	0.040	1.29	2.49 (1.05–5.90)
AG	40	38.09	96	50	0.052	1.18	1.62 (1.00–2.63)
GG	58	55.23	67	34.89	0.0009	0.73	0.43 (0.26–0.70)
AG and GG	98	93.33	163	84.89	0.040	0.77	0.40 (0.16–0.95)
A-allele	54	25.71	154	40.10	0.0001	1.83	4.20 (2.90–6.09)
G-allele	156	74.28	230	59.89	0.0004	1.55	1.93 (1.33–2.80)
rs4239242	(N = 109)	%	(N = 192)
TT	17	15.59	10	5.20	0.0032	0.54	0.28 (0.12–0.64)
TC	21	19.26	127	66.14	0.0001	2.03	7.99 (4.59–13.91)
CC	71	65.13	55	28.64	0.0001	0.55	0.22 (0.13–0.36)
TC and CC	92	84.40	182	94.79	0.0054	1.79	3.36 (1.48–7.64)
T-allele	55	25.22	147	38.28	0.0019	1.21	1.77 (1.23–2.55)
C-allele	163	74.77	237	61.71	0.0019	0.82	0.56 (0.39–0.80)